Welcome to the Working Group on New TB Drugs Blog
Announcement: Call for Papers on Antimicrobial Resistance
The Revista Panamericana de Salud Pública / Pan American Journal of Public Health, published by the Pan American Health Organization, announces an open call for original papers, brief communications, and reviews for its next special issue, which will cover topics related to antimicrobial resistance.
USAID Head: TB Drug Research Critical in Turning Tide Against Epidemic
Dr. Rajiv Shah, Administrator of the United States Agency for International Development (USAID) presented the most recent David E. Barmes Global Health Lecture on Tuesday, February 15, 2011 on the NIH Campus in Bethesda, Maryland.
New Intensive Course on TB Diagnostics
“Advanced TB Diagnostic Research: An intensive, high-level course on TB diagnostic research methods” will be held July5-8, 2011 in Montreal, Quebec, Canada. This advanced course will cover the principles behind diagnostic research, diagnostic study designs, sources of bias, and value chain for TB diagnostics development.
Stop TB Partnership Announces New Executive Secretary
Dr Lucica Ditiu has been appointed Executive Secretary of the Stop TB Partnership. A native of Romania, Dr Ditiu is a physician and researcher who has devoted her career to improving the lives of people living in communities heavily burdened by tuberculosis (TB).
WHO Endorses New Rapid Diagnostic Test for TB
Yesterday, Mario Raviglione , Director of Stop TB, and Giorgio Roscigno, CEO of FIND, held a global press conference announcing the World Health Organization’s endorsement of the new rapid diagnostic test Xpert MTB/RIF. If implemented to scale in countries where tuberculosis (TB) is endemic, it could revolutionize how TB is diagnosed and treated. The test could have a significant impact on patients that are smear negative, HIV positive, or infected with drug-resistant TB.
World AIDS Day Recap: The WHO issues new guidelines for TB prevention for people with HIV
On World AIDS day, the WHO Department of HIV/AIDS and the Stop TB Department issued new guidelines showing how people with HIV can be protected from tuberculosis with regular and low-cost preventive medication.
WGND 2010 Annual Meeting: Panel Discussion
Following the guest speakers, several representatives from companies conducting clinical trials of TB drug candidates presented brief updates on progress made in the clinical development of their candidates. We recap the presentations here and offer .pdf downloads of the original presentations.
WGND 2010 Annual Meeting Recap
Thank you to everyone who was able to join us in Berlin. This recap summarizes the work that was presented at our Annual Meeting on November 12. Co-chairs of WGND, Mel Spigelmen and Bill Bishai opened the annual meeting by welcoming the attendees and briefly reviewing the agenda for the meeting.
2010 Annual Meeting Recap – Photo Gallery
Photos from our 2010 Annual Meeting on November 12 in Berlin, Germany.
Report from NIH/NIAID Town Hall on HIV/AIDS Clinical Trial Network Restructuring
Lisan Parker was on hand at the Town Hall Meeting to Examine the Restructuring of the NIH/NIAID Clinical Trials Networks for HIV/AIDS & Other Infectious Diseases and filed this report.
-
You are currently browsing the archives for the Events category.
-
Toppix TB News- Editorial: Lives at risk if the U.S. shortchanges Global Fund 4 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- WHO says TB in Russia displays highest known drug resistance 3 Feb 2012
- Media outlets examine Global Fund's future as it enters second decade 3 Feb 2012
